Trial intelligence / Profile preview

Intranasal Ketamine for Venipuncture in Pediatric Patients

NCT02929524Phase 3Completed

Sponsor
Hospital de Clínicas de Porto Alegre
Start
Apr 2015
Primary completion
Oct 2016
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial in acute pain comparing Ketamine Group with Placebo Group (2 arms). Primary endpoint: Decreased venipuncture Time. Started Apr 2015; status: completed.

02

Drugs

ketamine
03

Conditions

acute pain

Beyond the preview

Go deeper on NCT02929524.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02929524.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call